Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness—a psychometric analysis using the PES100 in controlled psychedelic studies
Kurt Stocker, Matthias Hartmann, Frederick S. Barrett, Willam Richards, Nathan D. Sepeda, Isabelle Straumann, Aaron Klaiber, Severin B. Vogt, Livio Erne, Laura Ley, A. Becker, Patrick Vizeli, Friederike Holze, Matthias E. Liechti
Religion Brain & Behavior March 31, 2026 DOI: 10.1080/2153599x.2026.2635353 via OpenAlex
Summary
AI-generated from the abstractAfter administration of LSD, psilocybin, mescaline, or DMT, mystical oneness—the core of mystical experience—showed dose-sensitive strong correlations with luminous light and renewal, and a moderate-to-strong correlation with ego disintegration. These findings from 386 healthy participants across 15 studies support a broader, dynamic model of mystical experience, where mystical oneness unfolds with ego disintegration, renewal, and luminous light. The results offer insights for psychedelic-assisted therapy.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 386 |
| Population | Healthy participants |
| Interventions | LSD psilocybin mescaline DMT |
| Topics | Mysticism |
| Keywords | Psychometrics Key lock Psychometric testing Psychotherapist |
| Key finding | Mystical oneness showed dose-sensitive strong correlations with luminous light and renewal, and a moderate-to-strong correlation with ego disintegration. |
Abstract
Mystical dynamics—the notion that mystical oneness may unfold involving ego disintegration, renewal, and luminous light—has been discussed anecdotally by psychedelic researchers and therapists but has not yet been empirically examined in controlled settings. This study investigated the occurrence and dose-dependency of mystical dynamics in healthy participants after administration of psychedelics. A total of 816 mystical-dynamics measurements were collected from 386 participants across 15 studies at two sites: University Hospital Basel (Switzerland) and Johns Hopkins University (USA). Participants received low to high doses of four serotonergic psychedelics: LSD, psilocybin, mescaline, and DMT. Mystical dynamics was assessed using five corresponding constructs from the Psychedelic Experience Scale (PES100): ego disintegration, distress, renewal, luminous light, and mystical (focusing on mystical oneness, the core of mystical experience). We hypothesized strong intercorrelations of mystical oneness with ego disintegration, renewal, and luminous light, and a dose-dependent intensity pattern. Results showed dose-sensitive strong correlations of mystical oneness with luminous light and renewal, and a moderate-to-strong correlation of mystical oneness with ego disintegration. These findings support a broader, dynamic model of mystical experience and offer novel insights relevant to psychedelic-assisted therapy, while acknowledging additional experiential features that may also associate with mystical oneness.